70.
Patenting The Life

Under the WTO's Agreement on Trade-Related Aspects of Intellectual Property Rights (TRIPS) agreement, the most insidious corporate victories to date have been the granting of patent protections to all genetic material. In 1980, the US Supreme Court ruled that a particular genetically engineered micro-organism could be patented. This patent right was extended by the US patent Office in 1985 to cover all genetically-engineered plants, seeds and plant tissue, and was further extended to cover all animals in 1987. In 1998 EU countries extended patent laws to cover patents on plants, humans and life forms.
Biotech companies are being snapped up by giant ‘Life Science' corporations in a race to consolidate the food and seeds industry which tripled in size between 1992 and 2002. It was worth around $2,000 billion a year in 2001. By May 2002, there were 1,457 biotechnology companies in the US with a total value of $224 billion. Market consolidation is acute, 70% of patents on staple food crops are held by six multinational corporations who can set the market price for them and block competition for 20 years, thereby monopolizing the market.
Biotech companies are being snapped up by giant ‘Life Science' corporations in a race to consolidate the food and seeds industry which tripled in size between 1992 and 2002. It was worth around $2,000 billion a year in 2001. By May 2002, there were 1,457 biotechnology companies in the US with a total value of $224 billion. Market consolidation is acute, 70% of patents on staple food crops are held by six multinational corporations who can set the market price for them and block competition for 20 years, thereby monopolizing the market.
Discussions regarding economic systems should not be based on ideologies of socialism or capitalism, but on the practicalities and realities of our modern world. Today, the reality is that thousands will die from a lack of food, water and medicine, because of the failure of the global economy to allow them to have access to these basics. At the same time, a few business people will have earned millions of dollars in wages, thanks to the same economic system. These extremes must be reconciled urgently.

Patenting costs can be up to $1 million, ensuring that those in the developing countries cannot possibly compete with the wealthy corporations. The
developing world, where 75% of people's livelihoods depend upon agriculture, is the source of 90 per cent of all biological resources. Yet transnational companies based in developed counties hold 97 percent of global patents. Since 1985 there have been 10,778 patents on plants registered in the US. Overall, patent applications at the World Intellectual Property Organization have soared from 3,000 in 1979 to 67,000 in 1997.
Commercially owned genetic varieties of such staples as cotton and soya beans have devastated farming communities in developing countries, who can no longer store seeds without paying corporations for the privilege. There has been widespread opposition to what has been deemed ‘bio piracy'. This is when biotechnology corporations, in their haste to secure financial advantages, patent varieties of plants, seeds and applications that already exist and remain in use by indigenous communities. The patenting of life goes against the sharing of traditional knowledge and the preservation of biodiversity and culture. This precedent is a major victory for corporations. The potential for future profit is almost limitless.
(Source: Rajesh Makwana, STWR, October 2006)
developing world, where 75% of people's livelihoods depend upon agriculture, is the source of 90 per cent of all biological resources. Yet transnational companies based in developed counties hold 97 percent of global patents. Since 1985 there have been 10,778 patents on plants registered in the US. Overall, patent applications at the World Intellectual Property Organization have soared from 3,000 in 1979 to 67,000 in 1997.
Commercially owned genetic varieties of such staples as cotton and soya beans have devastated farming communities in developing countries, who can no longer store seeds without paying corporations for the privilege. There has been widespread opposition to what has been deemed ‘bio piracy'. This is when biotechnology corporations, in their haste to secure financial advantages, patent varieties of plants, seeds and applications that already exist and remain in use by indigenous communities. The patenting of life goes against the sharing of traditional knowledge and the preservation of biodiversity and culture. This precedent is a major victory for corporations. The potential for future profit is almost limitless.
(Source: Rajesh Makwana, STWR, October 2006)
The Global Economy
Corporations should exist as an integral component of a global economy that prioritizes the provision of basic needs for the global public - economic, social, political and spiritual. The primary objective of the global economy should not be commerce, trade liberalization or economic growth, but the production and distribution of all resources that are essential to life. International consensus must eventually lead to a clear demarcation with regards to what can be commoditized and what cannot be.